Finance

Lists
TSPC:IDX
Tempo Scan Pacific Tbk PT
IDR 2,210.00
+0.45%
(+10.00) 1D
Nov 12, 11:57:05 AM GMT+7  ·   IDR
All symbols
SymbolPriceChange% Change
Generating top insights for TSPC...
Open
IDR 2,200
High
IDR 2,220
Low
IDR 2,170
Mkt. cap
9.97T
Avg. vol.
639.64K
Volume
242.20K
Dividend
5.66%
Quarterly dividend
IDR 31
Ex-dividend date
Jun 17, 2026
P/E ratio
7.41
52-wk high
IDR 3,220
52-wk low
IDR 2,170
EPS
IDR 298
Shares outstanding
4.51B
No. of employees
4K
Open
IDR 2,200
High
IDR 2,220
Low
IDR 2,170
Mkt. cap
9.97T
Avg. vol.
639.64K
Volume
242.20K
Dividend
5.66%
Quarterly dividend
IDR 31
Ex-dividend date
Jun 17, 2026
P/E ratio
7.41
52-wk high
IDR 3,220
52-wk low
IDR 2,170
EPS
IDR 298
Shares outstanding
4.51B
No. of employees
4K
News stories
From web sources and news partners
About Tempo Scan Pacific Tbk PT
CEO-
Employees4.37K
Founded1970
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitetemposcangroup.com
Previous reportsAll values in IDR
Loading Previous Earnings...
Revenue
Net income
All values in IDR
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
3.87T
3.41T
3.70T
3.89T
Cost of goods sold
2.36T
2.14T
2.34T
2.57T
Cost of revenue
2.36T
2.14T
2.34T
2.57T
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.19T
924.33B
965.06B
1.01T
Operating expense
1.18T
887.10B
860.67B
1.00T
Total operating expenses
3.54T
3.03T
3.20T
3.57T
Operating income
331.85B
385.84B
499.78B
314.89B
Other non operating income
-1.25B
-3.42B
-140.99M
-
EBT including unusual items
356.58B
409.30B
531.98B
343.06B
EBT excluding unusual items
358.04B
412.69B
532.78B
345.68B
Income tax expense
77.12B
59.31B
95.86B
79.19B
Effective tax rate
21.63%
14.49%
18.02%
23.08%
Other operating expenses
-19.09B
-37.23B
-104.39B
-10.49B
Net income
270.45B
351.81B
422.96B
275.74B
Net profit margin
6.99%
10.31%
11.44%
7.10%
Earnings per share
-
-
-
-
Interest and investment income
47.94B
44.60B
48.95B
52.10B
Interest expense
-15.57B
-14.38B
-15.73B
-21.29B
Net interest expenses
32.37B
30.23B
33.23B
30.81B
Depreciation and amortization charges
-
-
-
-
EBITDA
398.14B
453.11B
584.73B
364.59B
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps